Asensus Surgical (FRA:2TX) Investments And Advances : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical Investments And Advances?

Asensus Surgical's Investments And Advances for the quarter that ended in Mar. 2024 was €0.00 Mil.

Asensus Surgical's annual Investments And Advances declined from Dec. 2021 (€33.13 Mil) to Dec. 2022 (€3.65 Mil) and declined from Dec. 2022 (€3.65 Mil) to Dec. 2023 (€0.00 Mil).

Asensus Surgical Investments And Advances Historical Data

The historical data trend for Asensus Surgical's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical Investments And Advances Chart

Asensus Surgical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Investments And Advances

Get a 7-Day Free Trial

33.13

3.65

Asensus Surgical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Investments And Advances	Get a 7-Day Free Trial															0.90	-	-	-	-

Asensus Surgical Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Asensus Surgical (FRA:2TX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

ASXC:USA

Address

1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703

Website

https://www.asensus.com

Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (FRA:2TX) Headlines

No Headlines